← Evidence map

TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2017

Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin.

Kazuhiro Nishikawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2017
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27822684